HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Abstract
To further refine our current nanoparticle-based HIV-1 p24 antigen assay, we investigated immune responses to p24 to identify diagnostically significant immune dominant epitopes (IDEs) in HIV-infected human sera, to address cross-reactivity of anti-p24 antibodies to different subtypes, and to identify new biomarkers that distinguish acute from chronic HIV infection for more accurate incidence estimation. We identified two major linear epitope regions, located in the CypA binding loop and adjacent helices and at the end of the C-terminal domain. Most sera (86%) from acutely HIV-1-infected individuals reacted with multiple peptides, while 60% and 30% of AIDS patient samples reacted with multiple and single peptides, respectively. In contrast, 46% and 43% of chronically HIV-1-infected individuals reacted with one and none of the peptides, respectively, and only 11% reacted with multiple p24 peptides, indicating a progression of immune responses from polyclone-like during acute infection to monoclone-like or a nonresponse to linear epitopes during chronic infection. Anti-p24 antibodies (subtype B) show broad cross-reactivity to different HIV-1 subtypes, and the synergistic action of different combinations of anti-HIV antibodies improves capture and detection of divergent HIV-1 subtypes. Our results indicate that the modified peptide immunoassay is sensitive and specific for the rapid identification of HIV-1 p24 IDEs and for investigation of immune responses to p24 during natural HIV-1 infection. The data provide the foundation for development and refinement of new assays for improved p24 antigen testing as future tools for rapid and accurate diagnosis as part of early intervention strategies and estimations of incidence.
AuthorsShixing Tang, Jiangqin Zhao, Aifeng Wang, Ragupathy Viswanath, Harri Harma, Richard F Little, Robert Yarchoan, Susan L Stramer, Phillipe N Nyambi, Sherwin Lee, Owen Wood, Eric Y Wong, Xue Wang, Indira K Hewlett
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 17 Issue 8 Pg. 1244-51 (Aug 2010) ISSN: 1556-679X [Electronic] United States
PMID20534793 (Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • HIV Antibodies
  • HIV Core Protein p24
  • Immunodominant Epitopes
  • p24 protein, Human Immunodeficiency Virus Type 1
Topics
  • Cross Reactions
  • Epitope Mapping
  • HIV Antibodies (blood)
  • HIV Core Protein p24 (immunology)
  • HIV Infections (diagnosis, immunology, virology)
  • Humans
  • Immunoassay (methods)
  • Immunodominant Epitopes (immunology)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: